Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Conference Proceeding
|
021: SEROPREVALENCE OF HISTOPLASMA CAPSULATUM INFECTION AMONG THE NEARBY RESIDENTS OF BAT CAVES IN ISLAND GARDEN CITY OF SAMAL, DAVAO DEL NORTEBMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.21 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.21Full text available |
|
2 |
Material Type: Conference Proceeding
|
033: BUILDING HEALTH RESEARCH IN THE UNIVERSITY OF THE PHILIPPINES (UP) FROM THE GROUND UPBMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.33 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.33Full text available |
|
3 |
Material Type: Conference Proceeding
|
046: EVALUATION OF A RESEARCH CAPACITY-BUILDING PROGRAM FOR HEALTH SCIENCES STUDENTS IN A PHILIPPINE UNIVERSITYBMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.46 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.46Full text available |
|
4 |
Material Type: Conference Proceeding
|
052: BARRIERS TO HEALTH RESEARCH USE IN KENYA AND MALAWIBMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.52 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.52Full text available |
|
5 |
Material Type: Conference Proceeding
|
058: EVALUATING A COMPLEX CAPACITY-BUILDING INTERVENTION IN AN INTERNATIONAL DEVELOPMENT CONTEXT: REFLECTING ON THE AFRICAN INSTITUTIONS INITIATIVE EVALUATIONBMJ open, 2015, Vol.5 (Suppl 1), p.bmjopen-2015-forum2015abstracts.58 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2015-forum2015abstracts.58Full text available |
|
6 |
Material Type: Conference Proceeding
|
1021 A pan-cancer signature identifies tumor-reacting CD8+ TILs and reveals their functional heterogeneityJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1064-A1064 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1021Full text available |
|
7 |
Material Type: Conference Proceeding
|
1093 A novel IL12-based immunocytokine targeting fibroblast activation protein (FAP) for the treatment of cancerJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1136-A1136 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1093Full text available |
|
8 |
Material Type: Conference Proceeding
|
111 Evaluation of survival outcomes from delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancerInternational journal of gynecological cancer, 2020, Vol.30 (Suppl 4), p.A56-A56 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-ESGO.101Full text available |
|
9 |
Material Type: Conference Proceeding
|
1121 Tigilanol tiglate is a naturally occurring small molecule oncolytic that effectively ablates tumors via intratumoural injection and can enhance response to immune checkpoint blockadeJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1165-A1165 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1121Full text available |
|
10 |
Material Type: Conference Proceeding
|
1135 Single cell resolution of immune responses to oncolytic herpes simplex virus C134 in preclinical medulloblastoma modelsJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1179-A1179 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1135Full text available |
|
11 |
Material Type: Conference Proceeding
|
1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primatesJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1198-A1198 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1155Full text available |
|
12 |
Material Type: Conference Proceeding
|
121 Systemic immune-inflammatory index (SII) as a prognostic factor for cervical cancer recurrenceInternational journal of gynecological cancer, 2020, Vol.30 (Suppl 3), p.A54-A55 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-IGCS.103Full text available |
|
13 |
Material Type: Conference Proceeding
|
122 Reconstructive plastic surgery using fasciocutaneous flaps in the surgical treatment of vulvar cancer (193 cases within the 1995-2015 time period)International journal of gynecological cancer, 2020, Vol.30 (Suppl 3), p.A55-A55 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-IGCS.104Full text available |
|
14 |
Material Type: Conference Proceeding
|
123 Minimally invasive surgery versus laparotomy in HGS EOC patients in a teaching referral centerInternational journal of gynecological cancer, 2020, Vol.30 (Suppl 3), p.A55-A56 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-IGCS.105Full text available |
|
15 |
Material Type: Conference Proceeding
|
1272 Probabilistic mixture models improve calibration of panel-derived tumor mutational burden in the context of both tumor-normal and tumor-only sequencingJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1320-A1321 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1272Full text available |
|
16 |
Material Type: Conference Proceeding
|
1445 AIM2 modulates azacytidine-induced antitumor immunity in lung cancerJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1505-A1505 [Peer Reviewed Journal]2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1445Full text available |
|
17 |
Material Type: Conference Proceeding
|
1996 Joint Scientific Meeting of the Research Society on Alcoholism and the International Society for Biomedical Research on AlcoholismAlcoholism, clinical and experimental research, 1996, Vol.20 (s2), p.1A-3A [Peer Reviewed Journal]1996 INIST-CNRS ;ISSN: 0145-6008 ;EISSN: 1530-0277 ;DOI: 10.1111/j.1530-0277.1996.tb01180.x ;CODEN: ACRSDMFull text available |
|
18 |
Material Type: Conference Proceeding
|
19th annual conference of the working group on kidney transplantation of the academy of german urologists : mainz, 10-12 november 2011Der Urologe. Ausg. A, 2012, Vol.51 (4), p.550-554EISSN: 1433-0563 ;DOI: 10.1007/s00120-012-2848-z ;PMID: 22437445Full text available |
|
19 |
Material Type: Conference Proceeding
|
2002 Scientific Meeting of the Research Society on Alcoholism and the 11th Congress of the International Society for Biomedical Research on Alcoholism, June 28 - July 3, 2002 - San Francisco, CaliforniaAlcoholism, clinical and experimental research, 2002, Vol.26 (5) [Peer Reviewed Journal]2002 INIST-CNRS ;ISSN: 0145-6008 ;EISSN: 1530-0277 ;CODEN: ACRSDMFull text available |
|
20 |
Material Type: Conference Proceeding
|
2003 Scientific Meeting of the Research Society on Alcoholism and the 12th Congress of the International Society for Biomedical Research on Alcoholism: June 21-June 25, 2003 - Fort Lauderdale, FloridaAlcoholism, clinical and experimental research, 2003, Vol.27 (5) [Peer Reviewed Journal]2003 INIST-CNRS ;ISSN: 0145-6008 ;EISSN: 1530-0277 ;CODEN: ACRSDMFull text available |